OOIR: Observatory of International Research

Papers

(The H4-Index of Allergy is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Issue Information	355
Issue Information	308
Preclinical Development of GR2002, a Novel Anti‐TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects	274
TOP10‐SCAR: A Global Pharmacovigilance Study on Medications Most Frequently Related to Severe Cutaneous Adverse Reactions	179
Type 2 memory B cells: The repository of allergic memory?	176
Issue Information	171
The Presence and Pathogenic Roles of M(IL‐33 + IL‐2) Macrophages in Allergic Airway Inflammation	170
Airway epithelial cell cilia transcriptomic dysregulation is associated with the inflammatory phenotype in asthma	125
Correspondence to “Basophil activation test as predictor of severity and threshold of allergic reactions to egg”	125
The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2	115
Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern	112
Core Outcome Set for IgE‐mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study ‘COMFA’	111
Adherence to Mediterranean Diet During Pregnancy, Breastfeeding, and Development of Food Allergy in the Offspring: Results From the MEDALLION Cohort Study	109
Pre‐existing inflammation reduces the response to contact allergens in Tmem79‐deficient mice	107
IgG Removal Enhances the Sensitivity of Amoxicillin‐Specific IgE Detection in ImmunoCAP and Radioallergosorbent Test	106
In vivo and ex vivo inflammatory responses of the esophageal mucosa to food challenge in adults with eosinophilic esophagitis	100
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures	96
Immunoglobulin E response in health and disease beyond allergic disorders	95
The impact of exposure to tobacco smoke and e‐cigarettes on asthma‐related outcomes: Systematic review informing the EAACI guidelines on environmental science for allergic diseases and asthma	92
Hot topics in allergen immunotherapy, 2023: Current status and future perspective	92
Angiomotin and angiostatin as asthma biomarkers: Implications for the regulation of airway remodeling and inflammation	91
Cryopreservation Between Sample Processing and Analysis in Streamlined Basophil Activation Test	86
Clinical applicability of the urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes	84
An algorithm for the diagnosis and management of IgE‐mediated food allergy, 2024 update	83
Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies	82

Long‐term safety and efficacy of garadacimab for preventing hereditary angioedema attacks: Phase 3 open‐label extension study	79
	79
In Memory of Dr. Izabela Kuprys‐Lipinska: A Pioneering Clinician, Scientist, and Beloved Friend	77
25‐hydroxyvitamin D and risk of atopic diseases and infections in early childhood	77
In memoriam: Lawrence M. Lichtenstein (1934–2022)	74
Prospective (e‐diary) vs retrospective (ARIA) measures of severity in allergic rhinoconjunctivitis: An observational compatibility study	73
Impact of COVID‐19 on care‐seeking patterns for hay fever in Japan: A retrospective claims database cohort study	70
MUC1 deficiency induces the nasal epithelial barrier dysfunction via RBFOX3 shortage augment ubiquitin–proteasomal degradation in allergic rhinitis pathogenesis	65
Correspondence to “Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma—Factor analysis”	65
Shotgun metagenomic sequencing on skin microbiome indicates dysbiosis exists prior to the onset of atopic dermatitis	64
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle	64
Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants	63
Efficacy and safety of intranasal medications for allergic rhinitis: Network meta‐analysis	63
Next generation health guidelines: The role of real‐life data in evidence‐based medicine	63
Dupilumab in Children Under 6 Years With Moderate‐to‐Severe Atopic Dermatitis: A 16‐Week Real‐World Prospective Study on Efficacy, Safety, and Local‐Systemic Immune Responses	60
Ficolin‐A Protects Against Allergic Asthma via Suppressing ILC2‐Drived Type 2 Inflammation	57
Algorithms in allergy: An algorithm for alpha‐Gal syndrome diagnosis and treatment, 2024 update	56
Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy	56
One‐strength dose escalation of house dust mite depot product for subcutaneous immunotherapy is safe and tolerable	55
Impact of climate change on atopic dermatitis: A review by the International Eczema Council	55
Development and validation of the food allergy severity score	54
The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3⁺ Tregs	54
Issue Information	54
Issue Information	53
Oral abstracts (OAS)	53
Issue Information ‐ TOC	53
Nutritional and environmental exposures in athletes: Implications on the epithelial barrier function	52